Zhengye Biotechnology Holding Limited (ZYBT)
NASDAQ: ZYBT · Real-Time Price · USD
0.6980
-0.0570 (-7.55%)
At close: Jul 17, 2026, 4:00 PM EDT
0.7550
+0.0570 (8.17%)
After-hours: Jul 17, 2026, 4:00 PM EDT

ZYBT Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jul '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
3355----
Market Cap Growth
-87.10%-----
Enterprise Value
36.3965.970000
Last Close Price
0.701.15----
PS Ratio
1.993.28----
PB Ratio
0.931.53----
P/TBV Ratio
0.170.28----
P/FCF Ratio
18.1830.95----
P/OCF Ratio
17.3528.61----
EV/Sales Ratio
2.193.97----
EV/FCF Ratio
20.0137.45----
Debt / Equity Ratio
0.240.240.220.260.180.09
Debt / EBITDA Ratio
--2.131.300.770.44
Debt / FCF Ratio
6.096.093.152.20-2.35
Net Debt / Equity Ratio
0.090.090.230.270.190.09
Net Debt / EBITDA Ratio
-0.52-0.521.641.070.650.35
Net Debt / FCF Ratio
1.881.882.421.80-5.521.86
Asset Turnover
0.250.250.380.420.540.48
Inventory Turnover
1.901.901.631.662.272.03
Quick Ratio
0.580.580.780.770.950.86
Current Ratio
1.141.141.311.261.411.31
Return on Equity (ROE)
-25.17%-25.17%3.89%10.78%16.50%14.57%
Return on Assets (ROA)
-16.38%-17.51%3.10%7.56%11.90%10.30%
Return on Invested Capital (ROIC)
-23.08%-21.74%3.70%9.35%15.22%13.39%
Return on Capital Employed (ROCE)
-20.94%-20.94%4.65%12.55%19.16%16.39%
FCF Yield
5.50%3.23%----
Payout Ratio
-0.00%141.66%125.42%45.84%23.78%
Buyback Yield / Dilution
-3.78%-3.69%0.00%0.00%0.00%-
Total Shareholder Return
-3.78%-3.69%0.00%0.00%0.00%-
SEC Filings: 10-K · 10-Q